Theratechnologies Inc. | Mutual Funds
Mutual Funds that own Theratechnologies Inc.
Caisse de Dépôt & Placement du Québec
4,313,700
6.54%
-950,000
0.01%
12/31/2017
Artisan International Small Cap Fund
1,122,094
1.7%
451,400
1.96%
06/30/2018
RBC OShaughnessy Canadian Equity Fund
579,417
0.88%
-250,870
0.86%
12/31/2017
DFA Canadian Small Company Series
299,501
0.45%
-75,700
0.22%
01/31/2018
RBC OShaughnessy All Canadian Equity Fund
200,664
0.3%
134,360
0.4%
12/31/2017
Desjardins Quebec Balanced Fund
156,967
0.24%
3,784
0.28%
04/30/2018
HSBC Small Cap Growth Fund
120,000
0.18%
-450,000
0.55%
12/31/2017
DFA International Core Equity Portfolio
100,800
0.15%
0
0%
04/30/2018
iShares S&P/TSX Small Cap Index ETF
78,190
0.12%
0
0.69%
09/06/2018
Exemplar Leaders Fund
57,000
0.09%
-10,800
1.6%
06/30/2018
| Address |
2015 Peel Street
Montréal Québec H3A 1T8
Canada
|
|
Employees
|
- |
| Website |
http://www.theratech.com |
| Updated |
07/08/2019 |
| Theratechnologies, Inc. is a pharmaceutical company, which engages in addressing medical needs of patients with Human Immunodeficiency Virus (HIV). It offers its product under the brand name of EGRIFTA, which approved therapy for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy. The company was founded on October 19, 1993 and is headquartered in Montreal, Canada. |
